NCT05703347 Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children
| NCT ID | NCT05703347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Insufficient Sleep |
| Study Type | INTERVENTIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2023-09-21 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5,000 participants in total. It began in 2023-09-21 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of this application is to develop a mobile health platform for the pediatric care setting to promote longer sleep duration for childhood obesity prevention.
Eligibility Criteria
Inclusion Criteria: 1. Aged 8-12 years olds. 2. Insufficient sleep duration (\<8.5 hours per night). 3. Body mass index (BMI) between the 50th and 95th percentile for age and sex. 4. One child per family. Exclusion Criteria: 1. Diagnosed with a chronic disease. 2. Diagnosed with a behavioral health problem. 3. Diagnosed with a condition that can impact sleep or growth. 4. Diagnosed with a condition affecting physical growth and maturation or dietary intake. 5. Children with a history of cancer, kidney, GI, musculoskeletal, or sleep disorders. 6. Children who will transition to high-school during the study. 7. Children using steroids/hormones. 8. Children regularly taking medications related to exclusionary medical conditions or that impact sleep. 9. Children with a history of significant behavioral health concerns. 10. Parent reported PROMIS Parent Proxy Sleep Disturbance - Short Form 8a raw score of ≥28.
Contact & Investigator
Jonathan Mitchell, PhD
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT05703347 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Insufficient Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05703347 currently recruiting?
Yes, NCT05703347 is actively recruiting participants. Contact the research team at mitchellj2@chop.edu for enrollment information.
Where is the NCT05703347 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05703347 clinical trial?
NCT05703347 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Jonathan Mitchell, PhD at Children's Hospital of Philadelphia. The trial plans to enroll 5,000 participants.